We are live on ! Find out more
LMR Partners

LMR Partners Portfolio holdings

AUM $32.6B Turnover 45.82%
1-Year Est. Return 45.61%
 

LMR Partners is a British multi-strategy investment firm named after its three founders, Ben Levine, Andrew Manuel and Stefan Renold, whose surname initials spell LMR. All three had been traders at UBS and Goldman Sachs, and Paloma Partners provided seed money before the firm began trading in 2010. Manuel left in 2015 and launched Ixworth Capital, his own global macro hedge fund. The firm focuses on global macro and event-driven strategies, mixing computer-model trading with trades chosen by its portfolio managers.

This Fund
S&P 500
This Quarter Est. Return
+4.46%
1 Year Est. Return
+45.61%
3 Year Est. Return
+238.3%
5 Year Est. Return
+283.63%
10 Year Est. Return
+733.38%
AUM
$32.6B
AUM Growth
+$5.8B
Cap. Flow
-$2.24B
Cap. Flow %
-6.88%
Top 10 Hldgs %
23.21%
Holding
1,999
New
513
Increased
354
Reduced
302
Closed
403
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.6 years

Top Buys

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$215M
2
NVS icon
Novartis
NVS
+$116M
3
LITE icon
Lumentum
LITE
+$91.8M
4
MDT icon
Medtronic
MDT
+$90.8M
5
SHOP icon
Shopify
SHOP
+$88.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 74.57%
2 Technology 7.25%
3 Healthcare 5.19%
4 Communication Services 3.16%
5 Financials 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
UAL icon
476
PUT
United Airlines
UAL
$35B
$8.88M 0.03%
80,000
+60,000
+300% +$7.07M
2026 Q1
2 quarters
HONA
477
Honeywell Aerospace
HONA
$50B
$8.84M 0.03%
57,039
+54,694
+2,332% +$9.9M
2026 Q2
1 quarter
BBY icon
478
Best Buy
BBY
$21B
$8.83M 0.03%
+100,077
New +$8.63M
2026 Q3
0 quarters
VAL icon
479
Valaris
VAL
$5.31B
$8.8M 0.03%
112,029
+51,963
+87% +$4.24M
2026 Q1
2 quarters
VRTX icon
480
Vertex Pharmaceuticals
VRTX
$136B
$8.8M 0.03%
16,823
+6,861
+69% +$3.51M
2025 Q3
4 quarters
COIN icon
481
Coinbase
COIN
$29.3B
$8.78M 0.03%
47,092
+26,207
+125% +$4.45M
2024 Q4
7 quarters
VRT icon
482
Vertiv
VRT
$74.9B
$8.76M 0.03%
36,300
-2,521
-6% -$687K
2025 Q4
3 quarters
FCX icon
483
CALL
Freeport-McMoran
FCX
$73.8B
$8.75M 0.03%
125,000
-169,300
-58% -$11.5M
2026 Q2
1 quarter
APA icon
484
CALL
APA
APA
$15.3B
$8.74M 0.03%
+210,400
New +$8.35M
2026 Q3
0 quarters
APA icon
485
PUT
APA
APA
$15.3B
$8.74M 0.03%
+210,400
New +$8.35M
2026 Q3
0 quarters
UMC icon
486
United Microelectronic
UMC
$35B
$8.73M 0.03%
356,448
+100,848
+39% +$2.16M
2026 Q2
1 quarter
CYRX icon
487
CryoPort
CYRX
$1.02B
$8.68M 0.03%
+499,070
New +$7.97M
2026 Q3
0 quarters
TDAC icon
488
Translational Development Acquisition Corp
TDAC
$210M
$8.66M 0.03%
800,000
– –
2025 Q1
6 quarters
SEI icon
489
CALL
Solaris Energy Infrastructure
SEI
$4.36B
$8.54M 0.03%
+120,000
New +$7.31M
2026 Q3
0 quarters
HIMS icon
490
Hims & Hers Health
HIMS
$4B
$8.53M 0.03%
+286,345
New +$8.79M
2026 Q3
0 quarters
TMTS icon
491
Spartacus Acquisition Corp II
TMTS
$307M
$8.52M 0.03%
+850,000
New +$8.55M
2026 Q3
0 quarters
NOK icon
492
Nokia
NOK
$43B
$8.48M 0.03%
836,433
-136,010
-14% -$1.41M
2025 Q1
6 quarters
XP icon
493
PUT
XP
XP
$7.13B
$8.47M 0.03%
+403,200
New +$7.16M
2026 Q3
0 quarters
RAC icon
494
Rithm Acquisition Corp
RAC
$312M
$8.43M 0.03%
800,000
– –
2025 Q3
4 quarters
AMGN icon
495
CALL
Amgen
AMGN
$240B
$8.43M 0.03%
+20,000
New +$7.97M
2026 Q3
0 quarters
QURE icon
496
CALL
uniQure
QURE
$1.42B
$8.41M 0.03%
348,000
+198,000
+132% +$8.59M
2026 Q1
2 quarters
SLP icon
497
DELISTED
Simulations Plus
SLP
$8.37M 0.03%
+454,049
New +$8.34M
2026 Q3
0 quarters
SNPS icon
498
Synopsys
SNPS
$83.2B
$8.37M 0.03%
19,234
+11,932
+163% +$4.87M
2026 Q2
1 quarter
BLUW icon
499
Blue Water Acquisition Corp III
BLUW
$338M
$8.3M 0.03%
800,000
– –
2025 Q4
3 quarters
OTGAU icon
500
OTG Acquisition Corp I Unit
OTGAU
$215M
$8.3M 0.03%
800,000
– –
2025 Q3
4 quarters

Similar funds

LMR Partners's Q3 2026 Portfolio in Review

As of Q3 2026, LMR Partners held 1,999 positions worth $32.6B, up 22% from $26.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

LMR Partners withdrew a net $2.24B in Q3 2026, closing 403 positions and reducing 302 holdings. Its most notable exit was Chart Industries, an estimated $109M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, up from 71% a quarter earlier, followed by Technology and Healthcare.

Against the trend, LMR Partners opened a new position in Lantheus worth $210M.

  • LMR Partners's largest Q3 2026 buy was Lantheus: 2,108,000 shares worth $210M.
  • LMR Partners added most to Novartis in Q3 2026, an estimated $116M increase.
  • LMR Partners's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $632M.
  • LMR Partners fully exited Chart Industries in Q3 2026, selling an estimated $109M.
  • LMR Partners's ten largest holdings make up 23% of its $32.6B portfolio in Q3 2026.
  • LMR Partners opened 513 new positions and closed 403 in Q3 2026.
  • LMR Partners's portfolio value rose 22% quarter-over-quarter to $32.6B.

Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.